• Clinical Insights: December 15, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval OrladeyoTM (berotralstat) Capsules – New Orphan Drug Approval – December 3, 2020 – BioCryst Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved oral,… Read more »

  • Clinical Insights: December 8, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Gallium 68 PSMA-11 (Ga 68 PSMA-11)  – New Drug Approval – December 1, 2020 – The U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11)… Read more »

  • Clinical Insights: December 1, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Imcivree®  (setmelanotide) Injection – New Drug Approval – November 27, 2020 – The U.S. Food and Drug Administration approved Imcivree®  (setmelanotide) for chronic weight management (weight loss and… Read more »

  • Clinical Insights: November 17, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Sutab® (sodium sulfate, magnesium sulfate, and potassium chloride) Tablets – New Drug Approval – November 10, 2020 – Sebela Pharmaceuticals® announced that the U.S. Food and Drug Administration… Read more »

  • Clinical Insights: November 10, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval SesquientTM (fosphenytoin sodium) Injection – New Drug Approval – November 5, 2020 – Sedor Pharmaceuticals, LLC announced that the U.S. Food and Drug Administration (FDA) has approved SesquientTM… Read more »

  • Clinical Insights: November 4, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Bronchitol® (mannitol) Inhalation Powder – New Drug Approval – October 30, 2020 – Chiesi USA, Inc., the U.S. affiliate of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group… Read more »

  • Clinical Insights: October 27, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Veklury® (remdesivir) Injection – New Drug Approval – October 22, 2020 – The U.S. Food and Drug Administration approved the antiviral drug Veklury® (remdesivir) for use in adult… Read more »

  • Clinical Insights: October 20, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval InmazebTM (atoltivimab, maftivimab, and odesivimab-ebgn) Injection – New Drug Approval – October 14, 2020 – The U.S. Food and Drug Administration approved InmazebTM (atoltivimab, maftivimab, and odesivimab-ebgn), a… Read more »

  • Celebrate National Pharmacy Week – October 18-24

    RxStrategies is are honored to recognize pharmacists and pharmacy technicians as they provide quality care in hospitals, health centers, pharmacies and other healthcare settings. Thank you for your invaluable contributions.   Learn more about the week >>

  • Clinical Insights: October 13, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval No new update. New Drug Shortage No new update. New Drug Recall and Safety Alerts No… Read more »